Rare diseases
Investigational molecules
Locations
1177 Avenue Of The Americas Floor 5th, 10036-2714, United States
Hoth Therapeutics Inc. focuses on skin toxicities associated with epidermal growth factor receptor inhibitors, with clinical interest in treatment-related acneiform rash and related cutaneous adverse effects seen during cancer therapy.
The sponsor’s research activity centers on managing therapy-induced skin complications in patients receiving epidermal growth factor receptor inhibitor treatment.
Hoth Therapeutics Inc. runs clinical trials in conditions such as Dermatitis acneiform, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
HungaryIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
